133 related articles for article (PubMed ID: 1713073)
1. Enhanced detection systems for enzyme-linked heterogeneous immunoassays: luminescence.
Edwards JC; Moon CR
Immunol Ser; 1990; 53():95-106. PubMed ID: 1713073
[TBL] [Abstract][Full Text] [Related]
2. Strategies for heterogeneous enzyme immunoassays for tumor markers.
King WJ; Tomita JT; Dowell BL; Delfert DM
Immunol Ser; 1990; 53():83-93. PubMed ID: 1713072
[No Abstract] [Full Text] [Related]
3. [A case of alpha-fetoprotein, carcinoembryonic antigen and human chorionic gonadotropin producing renal cell carcinoma].
Takakura N; Mimura H; Hamazaki K; Kim H; Hirata K; Miwata H; Kimura T; Sakata T; Hosoba T; Orita K
Gan No Rinsho; 1987 Sep; 33(11):1385-90. PubMed ID: 2444728
[TBL] [Abstract][Full Text] [Related]
4. [Tumor markers].
Cappelaere P
Rev Prat; 1988 Jun; 38(17):1058-63. PubMed ID: 2457249
[No Abstract] [Full Text] [Related]
5. [The level of embryonic antigens in the blood serum and cerebrospinal fluid of neuro-oncological patients].
Rudenko VA; Lisianyĭ NI; Grinevich IuA; Burkatovskaia MB; Iugrinova LG
Zh Vopr Neirokhir Im N N Burdenko; 1996; (3):32-5. PubMed ID: 8975514
[TBL] [Abstract][Full Text] [Related]
6. [Carcinoembryonic antigen, alpha-fetoprotein and human chorionic gonadotropin producing gastric cancer].
Honda T; Katusima S; Tokuda Y; Matuda K; Oonisi Y; Taniguchi T; Oomoto J; Kawaguchi Y
Nihon Naika Gakkai Zasshi; 1984 Apr; 73(4):521-6. PubMed ID: 6206171
[No Abstract] [Full Text] [Related]
7. [Gastric cancer with bone metastasis from the viewpoint on oncodevelopmental gene products].
Ohyama S; Yonemura Y; Hashimoto T; Sawa T; Miwa K; Miyazaki I
Nihon Gan Chiryo Gakkai Shi; 1987 Jun; 22(5):1013-9. PubMed ID: 2447212
[No Abstract] [Full Text] [Related]
8. Tumour markers.
Pandha HS; Waxman J
QJM; 1995 Apr; 88(4):233-41. PubMed ID: 7540924
[TBL] [Abstract][Full Text] [Related]
9. Immunocytochemical evaluation of human esophageal neoplasms and preneoplastic lesions for beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
Burg-Kurland CL; Purnell DM; Combs JW; Hillman EA; Harris CC; Trump BF
Cancer Res; 1986 Jun; 46(6):2936-43. PubMed ID: 2421889
[TBL] [Abstract][Full Text] [Related]
10. Enzyme-linked heterogeneous immunoassays with electrochemical detection.
Halsall HB; Jenkins SH; Heineman WR
Immunol Ser; 1990; 53():107-24. PubMed ID: 2100550
[No Abstract] [Full Text] [Related]
11. Oncofetal and oncoplacental antigens as tumor markers.
Yamauchi S; Miyake H
Kitasato Arch Exp Med; 1988 Sep; 61(2-3):95-109. PubMed ID: 2463397
[No Abstract] [Full Text] [Related]
12. Non-invasive cancer detection: strategies for the identification of novel cancer markers.
Sorio C; Mauri P; Pederzoli P; Scarpa A
IUBMB Life; 2006 Apr; 58(4):193-8. PubMed ID: 16754296
[TBL] [Abstract][Full Text] [Related]
13. Establishment and characterization of a seminoma cell-line (S2).
von Keitz AT; Riedmiller H; Neumann K; Gutschank W; Fonatsch C
Investig Urol (Berl); 1994; 5():28-31. PubMed ID: 7536523
[No Abstract] [Full Text] [Related]
14. Serum tumor markers.
Klee GG; Go VL
Mayo Clin Proc; 1982 Feb; 57(2):129-32. PubMed ID: 6172679
[No Abstract] [Full Text] [Related]
15. [Tumor markers--possibilities and limitations].
Rose H; Saul G; Wolf G; Moldenhauer H; Kehrberg G
Radiobiol Radiother (Berl); 1984; 25(1):7-19. PubMed ID: 6203136
[No Abstract] [Full Text] [Related]
16. [Serodiagnosis: tumor marker].
Yoneshima M; Hattori N; Sawabu N
Gan No Rinsho; 1988 Aug; 34(10):1209-15. PubMed ID: 2459425
[TBL] [Abstract][Full Text] [Related]
17. [Biologic markers of cancer. Towards a selective use for the detection and surveillance of malignant tumors].
Bellet D; Bidart JM
Rev Prat; 1989 Nov; 39(26):2350-4. PubMed ID: 2480633
[No Abstract] [Full Text] [Related]
18. Significance of CEA, AFP, SP1 and HCG as tumor markers in ovarian carcinoma.
Pulay T; Csömör S; Mészáros K; Szarka G; Csabay L; Szinnyai A
Neoplasma; 1987; 34(5):595-600. PubMed ID: 2447510
[TBL] [Abstract][Full Text] [Related]
19. [Radioimmunoassays in oncology].
Dressler J
Fortschr Med; 1983 Mar; 101(11):451-4. PubMed ID: 6189774
[TBL] [Abstract][Full Text] [Related]
20. Use of tumour markers in cancer diagnosis and treatment.
Higgins C
Nurs Times; 1996 Apr 17-23; 92(16):36-7. PubMed ID: 8710591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]